ClinConnect ClinConnect Logo
Search / Trial NCT04957238

Physical Restraints in Intensive Care Unit Patients

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jun 30, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Icu Physical Restraints Safety Agitation Delirium Nursing Care Sedation Family Invasive Devices

ClinConnect Summary

This clinical trial is studying the use of physical restraints in patients who are critically ill and being treated in the Intensive Care Unit (ICU). Physical restraints are sometimes used to keep patients safe, especially if they might accidentally pull out important medical devices like IV lines. However, these restraints can also lead to feelings of confusion and agitation. To address this, researchers have developed a decision-making tool that helps healthcare providers decide when it is appropriate to use restraints, based on objective assessments of a patient’s mental state.

To be eligible for this study, participants must be over 18 years old and have been in the ICU for at least 48 hours. They need to agree to participate, or their family member or trusted person can provide consent on their behalf. Throughout the study, participants can expect careful monitoring and support as the team evaluates the effectiveness of the new decision-making tool. This trial aims to improve patient care by reducing unnecessary use of restraints and enhancing safety in the ICU.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient, male or female, over 18 years of age, hospitalized in ICU for at least 48 hours.
  • Consent to participate in the patient's study or authorization to carry out the research collected from the designated trustworthy person (failing this, a family member, or failing this, a close and stable relation with the person concerned) according to the modalities described in Title II of the book of the First Public Health Code. If no relative is present, the patient may be included on the advice of the investigator (article L. 1111-6). A consent form for continuation of the study and use of the data will then be signed by the patient if and when the patient is again conscious and lucid, or if the patient is unable to express consent, authorization to continue the research will be obtained from the designated trusted person.
  • Patient covered by a social security system.
  • Exclusion Criteria:
  • Predictable and uninterrupted maintenance of deep sedation throughout the duration of the stay, due to the seriousness of the lesions, from the moment the patient is admitted to the intensive care unit.
  • Lack of predictable remission of a severe coma present on admission to intensive care.
  • Refusal to participate by the patient, or by the trusted person contacted by default.
  • Patient with DNR (do not resuscitate) orders.
  • Patient under legal protection.
  • Patient already included in the protocol during another stay in resuscitation

About University Hospital, Clermont Ferrand

The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.

Locations

Annecy, , France

Clermont Ferrand, , France

Paris, , France

Montpellier, , France

Aurillac, , France

Nice, , France

Belfort, , France

Dijon, , France

Strasbourg, , France

Saint Malo, , France

Avignon, , France

Cergy Pontoise, , France

Clermont Ferrand, , France

Lyon, , France

Marseille, , France

Marseille, , France

Montluçon, , France

Poissy, , France

Rodez, , France

Saint étienne, , France

Salon De Provence, , France

Vichy, , France

Le Puy En Velay, , France

Moulins, , France

Strasbourg, , France

Strasbourg, , France

Patients applied

0 patients applied

Trial Officials

Périne Vidal

Principal Investigator

CHU de Clermont-Ferrand

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials